MPWT
PACB icon

MassMutual Private Wealth & Trust’s Pacific Biosciences PACB Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-517
Closed -$708 – 2231
2024
Q2 		$708 Buy
+517
New +$1.04K ﹤0.01% 1902
2023
Q4 		– Sell
-66
Closed -$551 – 2050
2023
Q3 		$551 Buy
+66
New +$754 ﹤0.01% 1800
2022
Q2 		– Sell
-59
Closed -$1K – 1656
2022
Q1 		$1K Buy
+59
New +$679 ﹤0.01% 1384

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

MassMutual Private Wealth & Trust's PACB Position: Q3 2024 in Review

MassMutual Private Wealth & Trust sold out of Pacific Biosciences (PACB) in Q3 2024, closing a stake of 517 shares — an estimated $708 sold.

MassMutual Private Wealth & Trust first reported a position in PACB in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

  • MassMutual Private Wealth & Trust reported no remaining Pacific Biosciences position as of Q3 2024 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 517 Pacific Biosciences shares in Q3 2024, an estimated $708.
  • MassMutual Private Wealth & Trust first reported a position in Pacific Biosciences in Q1 2022 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's Pacific Biosciences position peaked at $1K in Q1 2022.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2024, filed 2 Oct 2024.